Kintor Pharmaceutical Announced U.S. FDA Has Greenlighted Phase II Clinical Trial for Pyrilutamide to Treat Androgenetic Alopecia

    Treatment 7/11/2021
    Chinese company gets green light for Pyrilutamide Phase II trial for androgenetic alopecia. Androgen receptors downregulate in androgen deficient environments.
    View this post in the Community →

    Similar Community Posts Join

    6 / 727 results

    Related Research

    6 / 8 results